You are currently viewing a new version of our website. To view the old version click .
Healthcare
  • Review
  • Open Access

13 November 2025

Linguistic Markers in Spontaneous Speech: Insights into Subjective Cognitive Decline (Review)

,
,
,
,
,
,
,
and
1
Centre for Research and Technology Hellas, Information Technologies Institute (CERTH/ITI), 57001 Thessaloniki, Greece
2
Institute of Applied Biosciences, Centre for Research and Technology Hellas (INAB|CERTH), 57001 Thessaloniki, Greece
3
Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08029 Barcelona, Spain
4
Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain
This article belongs to the Section Digital Health Technologies

Abstract

Background and Objectives: Population rapid growth and demographic shift is leading to a rise in neurodegenerative disorders such as dementia and mild cognitive impairment (MCI). Evidence indicates that MCI is not the earliest phase of prodromal AD. Subjective Memory Decline (SMD) refers to a self-perceived decline in cognitive abilities compared to previous functioning levels in individuals with normal cognition. Language impairment represents a critical marker of neurodegenerative disorders and early memory decline in healthy older adults. Methods: This review was conducted in accordance with PRISMA Statement guidelines. The inclusion criteria of the selection process were set as follows: (1) All studies analyzed spontaneous speech samples in individuals with SMD or individuals with +αβ amyloid. (2) Studies reported language performance indicators (e.g., lexical, syntactic, semantic, phonetic, or fluency measures) derived from spontaneous speech. (3) The study population included participants with SMD based on recognized diagnostic criteria or self-reported cognitive complaints without objective cognitive impairment. (4) Studies were written in English. (5) The time frame of studies was 5 years. Results: The present work is a review of speech features—particularly from spontaneous and narrative speech—and methods that can serve as sensitive indicators of early cognitive changes due to AD pathology. Conclusions: Spontaneous speech analysis, through acoustic and temporal parameters such as silence duration, phrasal segment length, and speech segment frequency, offers a rich window into the subtle cognitive and linguistic changes that reflect early memory decline in healthy older adults. Spontaneous speech performance could be a scalable, low-cost, and non-invasive diagnostic tool in proactive cognitive health.

1. Introduction

Population rapid growth and demographic shift is leading to a rise in neurodegenerative disorders such as dementia and mild cognitive impairment (MCI) []. MCI represents a transitional phase between normal aging and dementia, where individuals retain most functional abilities despite exhibiting neuropsychological impairments [], and is considered a significant risk factor for Alzheimer’s disease (AD) []. Extensive research has explored MCI as a predictor of AD, including the development of psychological assessments targeting cognitive domains affected by MCI and dementia to distinguish healthy individuals from those exhibiting clinical symptoms [].
However, evidence indicates that MCI is not the earliest phase of prodromal AD, highlighting the need for earlier disease detection to enable more effective interventions [,]. Some individuals report experiencing subtle changes in memory and cognitive function before any detectable cognitive impairment. Subjective Memory Decline (SMD) refers to a self-perceived decline in cognitive abilities compared to previous functioning levels in individuals with normal cognition [,] and has been recognized as a key factor in identifying prodromal AD []. The association between SMD and actual memory function remains unclear. Thus, those experiencing SMD report subjective memory issues or changes that are too minor to be detected by standard cognitive assessments []. However, individuals with these concerns tend to exhibit greater objective memory decline, lower overall cognitive performance, and poorer perceived health compared to those without SMD []. In the literature, SMD is also referred to as subjective cognitive decline (SCD), subjective memory impairment (SMI), and subjective cognitive complaint (SCC). While these terms vary slightly in definition, they all generally describe an individual’s subjective perception of their cognitive abilities.
Although there are no globally accepted or widely used criteria for diagnosing SCD, according Jessen and colleagues (2014), the SCD-I Working Group has introduced the SCD-plus criteria as a guideline []. These criteria incorporate biomarkers along with specific characteristics, such as self-perceived memory decline and the perception of having worse memory performance compared to peers of the same age. According to the SCD-I Working Group, the diagnostic criteria for SCD include (a) a subjective sense of worsening memory that is not linked to depressive symptoms, (b) the absence of objective cognitive deficits based on neuropsychological assessments, and (c) classification at stage 2 of the disease as defined by the Global Deterioration Scale (CDR) [].

1.1. Spontaneous and Connected Speech as Markers of Detection in Cognitive Decline

Language impairment represents a critical marker of neurodegenerative disorders; however, the absence of a standardized terminology system for characterizing these impairments contributes to substantial inter-rater variability among clinicians. Recently, the application of natural language processing (NLP) techniques and automated speech analysis (ASA) has emerged as a novel and potentially more objective approach for evaluating language function in individuals with mild cognitive impairment (MCI) and Alzheimer’s disease (AD) [].
Spontaneous speech is speech produced with minimal premeditation, constitutes effortless, natural, content-driven, and meaningful communication, and is used to describe unscripted, real-life verbal production reflecting cognitive–linguistic processes []. Studies have shown that individuals with high amyloid burden, a hallmark of Alzheimer’s pathology, exhibit a reduction in the use of specific words during spontaneous speech tasks. Other studies have focused on word count in semantic fluency or picture description tasks for classification purposes among MCI, SMD, and healthy older adults [,]. Moreover, machine learning techniques applied to paralinguistic features from brief spontaneous speech protocols have proven effective in distinguishing between varying degrees of cognitive impairment, including SCD, MCI, and AD []. These findings underscore the potential of speech analysis as a non-invasive, cost-effective method for early detection and monitoring of cognitive decline.
The analysis of connected speech has gained increasing importance over the past two decades, particularly in AD research, due to its ability to simultaneously engage multiple cognitive processes such as semantic storage and retrieval, executive functions, and working memory.
Connected speech is a term used to refer to any spoken language that flows continuously, not just isolated words, including all the sound changes that happen when one word connects to another in spontaneous speech [].
Specifically, it refers to continuous sequences of spoken language where words flow naturally and phonetic/phonological processes (like assimilation, elision, and liaison) occur across word boundaries. Compared to isolated tasks like picture naming, connected speech offers a more comprehensive and ecologically valid assessment with minimal participant burden []. Although most studies have focused on individuals with mild to moderate AD, retrospective analyses [,] have identified linguistic changes as early as the MCI stage. Nevertheless, detecting subtle, preclinical language impairments remains challenging, partly due to the strong interdependence of language and memory functions and the lack of standardized methods to differentiate between them. Furthermore, distinguishing language changes in MCI from those related to normal aging or SCD is difficult []. Simultaneously quantifying both memory and language impairments may enhance diagnostic sensitivity and provide valuable prognostic information.

1.2. Speech Domains Connected to AD, MCI, and SMD

While episodic memory impairment or memory loss is a defining feature of AD, patients also develop key language deficits as a consequence of multiple cognitive impairments due to focal brain damage []. These can manifest as a decline in lexical semantic knowledge and difficulties in finding the right words (i.e., anomia and semantic paraphasias), and following a conversation, their fluency and rate of speech (phonetic level) are reduced while using grammatically correct but content-poor sentences [,,,,]. Based on a number of studies, morphosyntactic processing remains mostly intact at first; nonetheless, individuals with AD make significantly more inflectional errors (mistakes with prefixes and suffixes that change a word’s form) than healthy older adults [,,,,]. Critically, at the pragmatic level, their ability to hold a cohesive conversation also suffers, impacting how they link ideas (referential/temporal cohesion), maintain clarity, and organize their speech [,,,].
Verbal deficits observed in MCI mirror those of early-/moderate-stage dementia [], specifically involving naming, verbal fluency, and semantic knowledge, where pragmatic skills seem to be the most affected area. It is well documented that these discourse issues are often the earliest detectable signs of AD pathology, sometimes appearing years before other memory or cognitive problems are formally diagnosed [,]. Therefore, analyzing these language markers is promising for both early detection and large-scale screening for dementia.
Studies regarding SMD deficits in language domains are sparse. However, some recent studies indicate that word-finding patterns, especially those related to specific and concrete words, may be sensitive indicators for early cognitive changes such as SMD [,,]. The association with amyloid burden in SMD populations further supports their potential as early biomarkers of Alzheimer’s disease pathology. Specifically, Verfaillie et al. (2019) found that less use of words referring to human characteristics and concrete nouns, as well a lower use of content words, was associated with higher amyloid burden []. This indicates that a reduction in the density of meaningful words in spontaneous speech may reflect underlying neuropathological changes. In a longitudinal study (5-year study follow-up), Maruta and Martins (2019) provide insight into word retrieval efficiency []. While not directly measuring word-finding difficulties, poorer performance on semantic fluency tasks over time may reflect increasing challenges in lexical access. Another longitudinal study (5-year follow-up) by Reeves et al. (2023) indicates that a reduced word count combined with an increased frequency of interjections, or a lower narrative discourse (ND) score, was a significant predictor of subsequent cognitive decline [].

1.3. Linguistic Metrics in Connected and Spontaneous Speech

Current traditional methods of linguistic skills’ evaluation, typically involving paper-and-pencil or computer-based tasks that measure verbal fluency, visual confrontation naming, comprehension, and writing skills, remain limited. These conventional tests often lack the sensitivity required for early diagnosis and disregard more complex language dimensions such as prosody and speech rhythm (suprasegmental features). As a result, even when these standardized tools detect minor differences between participants with MCI and healthy older adults, their overall clinical utility is questionable and unreliable [,,]. In recent years, the application of sophisticated natural language processing (NLP) techniques has revolutionized the analysis of language skills. By processing written texts, structured clinical speech, and spontaneous conversation, detailed linguistic features can be automatically extracted to help identify, classify, and describe signs of various psychiatric and neurological disorders. These computational methods have already proven successful in detecting the subtle linguistic markers that signal the very early stages of dementia [,,,] and characterizing associated conditions like AD [,,,].
With regard to metrics, research has indicated that “idea density” and “grammatical complexity” serve as indicators of dementia risk, with lower baseline levels of these measures linked to the development of dementia []. “Idea density”, or “propositional idea density (P-density)”, refers to the proportion of semantic content words relative to the total number of words in a sentence []. Other linguistic metrics used in connected language studies to assess semantic content include the ratio of nouns to the total number of pronouns and nouns, which quantifies “nonspecific language” by identifying pronouns without clear referents []. Additionally, connected language analysis has been used to measure grammatical complexity through verb percentage or verb indices [] and to assess coherence and informativeness. A feature taxonomy has been described by de la Fuente Garcia (2020) [] with regard to the metrics that have been defined per layer in spontaneous speech production: lexical features, syntactical features, semantic features, pragmatic features, prosodic features, spectral features, vocal quality, and ASR-related features.

1.4. Tools to Measure Connected and Spontaneous Speech

Language samples have also been collected through more structured elicitation methods, such as open-ended questions or semi-structured interviews. For example, participants have been asked to describe “the happiest moment of their lives” [] or to respond to general questions regarding their career, family, life experiences, and hobbies [,] in order to measure spontaneous speech. Other studies of connected speech have utilized more constrained tasks, such as picture description. While open-ended methods yield greater linguistic output, they tend to be highly variable across individuals and contexts, making standardization for comparative analysis challenging. In contrast, picture description tasks offer a structured means of assessment with standardized evaluation measures, and when the picture remains visible, they place less demand on episodic memory. The most frequently used picture stimuli in the literature include Norman Rockwell prints, such as “Easter Morning” [], and the widely recognized “Cookie Theft” picture from the Boston Diagnostic Aphasia Examination []. The “Cookie Theft” picture is particularly notable, as it was designed to encompass elements of a person, time, place, and action while incorporating vocabulary that is typically acquired early in life [].
Recent studies have employed various semi-spontaneous speech tasks. For example, one study protocol used three different prompts such as describing a complex image, detailing a typical working day, and recounting the last dream remembered [].
Although there is extensive research on picture description in AD, studies focusing on this method in mild cognitive impairment (MCI) remain comparatively limited. However, smaller retrospective studies suggest that language decline may emerge in prodromal phases of the disease [,]. Picture description tasks could be valuable in detecting linguistic changes at the MCI or pre-MCI stage, like the SMD group, aiding in early diagnosis and identifying the optimal time to introduce cognitive–communication interventions.

1.5. Aim of the Review

The purpose of this literature review is to examine methods or tools for assessing language performance in individuals with SMD. Specifically, it aims to explore quantitative metrics and indicators of spontaneous speech that may serve as early markers of cognitive decline. By identifying such speech-based indicators, this review seeks to inform early diagnosis and help determine the optimal timing for initiating cognitive–communication interventions for individuals at risk of AD.
Research Questions:
  • What characteristics of spontaneous speech have been used to detect cognitive decline in individuals with SMD?
  • What linguistic metrics are used (e.g., phonological, syntactic, semantic, pragmatic, etc.)?
  • What tools or methods are employed to analyze spontaneous and connected speech.

2. Materials and Methods

2.1. Search Strategy

A systematic literature search was conducted using two widely recognized databases: PubMed and Cochrane. The search employed a combination of keywords, subject headings, and MESH terms related to themes of Subjective Memory Decline and Spontaneous Speech (detailed in the Supplementary Materials). The initial systematic search took place in March 2025.

2.2. Procedure, Selection Process, and Data Extraction

This review was conducted in accordance with PRISMA Statement guidelines []. Following the removal of duplicates, two reviewers (A.N. and M.G) independently screened articles based on their title, abstract, and relevance. Full-text screening was then performed for studies deemed potentially eligible. A third reviewer (MG) was involved to resolve any discrepancies between the initial two reviewers at each stage of the selection process. The inclusion criteria of the selection process were set as follows: (1) All studies analyzed spontaneous speech samples in individuals with SMD or individuals with +αβ amyloid. (2) Studies reported language performance indicators (e.g., lexical, syntactic, semantic, phonetic, or fluency measures) derived from spontaneous speech. (3) The study population included participants with SMD based on recognized diagnostic criteria or self-reported cognitive complaints without objective cognitive impairment. (4) Studies were written in English. (5) The time frame of studies was 5 years. The exclusion criteria were set as follows: (1) Studies focusing primarily on language markers in populations with MCI, AD, or other neurodegenerative conditions, without a distinct SMD or +αβ amyloid group. (2) Studies that assessed language performance using only structured or experimental tasks (e.g., naming tests, sentence repetition) without spontaneous speech analysis. (3) Case studies, reviews, opinion papers, reports, protocols, or meta-analyses. (4) Studies examining speech and language in psychiatric or neurological conditions unrelated to cognitive decline (e.g., aphasia, schizophrenia, stroke).
Any disagreements regarding eligibility criteria were resolved by a third reviewer (MG). Data extraction was performed independently by MG and SS using a standardized template that captured the following elements: 1. study/year; 2. methodology; 3. tools; 4. outcome measured; and 5. main findings.

2.3. Data Synthesis Strategy

The synthesis was carried out according to the methodology, the setting/participants, the tools used, the outcomes measured, and the main findings of the selected studies. These dimensions were used to interpret the findings and draw conclusions about language indicators in SCD.

3. Results

The review of the studies selected regarding the target group of SCD provided a full list of details according to the methodology, tools used, outcomes, and main findings, as summarized in Table 1.
Table 1. Review of selected studies according to language indicators in SCD.
Most of the studies had a cross-sectional design [,,,,,,,,], except for van den Berg (2025) [] and Reeves (2023) [], which were longitudinal; Ter Huurne (2023) [], which was a prospective cohort study; and Hajjar (2023) [], which was a cross-sectional study with a 2-year follow-up.

3.1. Articulatory and Prosodic Markers in Spontaneous Speech

The findings of the current review indicate that articulatory and prosodic features of spontaneous speech may serve as early indicators of cognitive decline in individuals with SMD. Specifically, slower speech rate, increased between-utterance pause time, and more frequent between-utterance pauses during delayed recall tasks have been significantly associated with elevated tau deposition in medial temporal and early neocortical regions, even in cognitively unimpaired adults []. These speech-based markers appeared to be independent of amyloid status and traditional delayed recall performance, suggesting their unique contribution to the early detection of Alzheimer’s pathology [].
Furthermore, the phoneme log-likelihood ratio (PLLR), a computational measure of articulatory precision, demonstrated robust discriminatory power between cognitively unimpaired individuals with low amyloid-β burden and those diagnosed with mild cognitive impairment (MCI) or dementia []. The sensitivity of the PLLR to subtle differences between groups with milder cognitive deficits supports its potential utility as an early speech-based biomarker of neurodegeneration []. Similarly, a reduction in speech fluency and pace has been observed in individuals with MCI and dementia relative to cognitively unimpaired controls, providing further support for the relevance of temporal and articulatory markers in characterizing preclinical stages of cognitive impairment [].

3.2. Lexical–Semantic and Language Content Features

Changes in the lexical and semantic properties of spontaneous speech have also emerged as potential indicators of early cognitive changes. Amyloid-positive individuals were found to produce fewer specific content words, particularly among highly educated participants, despite showing no significant alterations in lexical or syntactic complexity on conventional neuropsychological assessments []. This suggests that spontaneous speech tasks may offer enhanced sensitivity to detect subtle semantic impairments in preclinical Alzheimer’s disease. Declines in semantic verbal fluency have been consistently associated with an increased risk of clinical progression from SMD to MCI or dementia. Notably, semantic fluency declined more rapidly in amyloid-positive individuals compared to their amyloid-negative peers, while phonemic fluency remained stable []. Furthermore, a growing discrepancy between semantic and phonemic fluency scores over time has been linked with subsequent progression to MCI or Alzheimer’s dementia, indicating the clinical relevance of fluency metrics as longitudinal markers of risk [].
The diagnostic utility of lexical–semantic and acoustic digital voice biomarkers was also supported by evidence showing that these features outperformed traditional neuropsychological tests in differentiating MCI from SCD []. Lexical–semantic indicators were able to detect amyloid-β status, while acoustic markers were correlated with hippocampal volume, reinforcing their biological validity []. Additionally, machine learning models analyzing paralinguistic features from spontaneous speech demonstrated high accuracy in identifying individuals with MCI and Alzheimer’s disease and predicting performance in multiple cognitive domains such as memory, executive function, and visuospatial ability [].

3.3. Automated Speech Analysis and Remote Assessment Tools

Evidence from the current review supports the feasibility and diagnostic relevance of remote and automated speech assessments for individuals with SMD. Studies have shown that automatic speech recognition (ASR) technologies exhibit high agreement with manual transcription for word count metrics, with a 93% probability that discrepancies remain within minimally important differences []. However, qualitative features such as semantic cluster size and word frequency showed only fair levels of agreement between automated and manual transcription, indicating current technological limitations in more complex linguistic analyses []. Notably, the diagnostic accuracy of automated speech features has been demonstrated to differentiate between cognitively unimpaired, SMD, MCI, and AD groups, particularly when analyzing spontaneous speech and verbal fluency tasks using mobile applications []. The application of these tools is further validated in studies showing the high classification accuracy and predictive capability of machine learning models that utilize ASR-derived features from verbal learning and recall tasks [].
Importantly, the performance of ASR systems is influenced by the clinical status of participants. Transcripts of speech from cognitively healthy individuals had higher recognition confidence and lower error rates than those from individuals with SMD, MCI, or AD. Manual correction of transcripts improved classification performance for spontaneous speech but had limited effect on reading tasks []. Furthermore, the PROSPECT-AD study highlighted the utility of remote speech-based neurocognitive assessments in identifying early Alzheimer’s biomarkers. The study emphasized the capacity of such speech features to correlate with CSF biomarkers such as amyloid-β1-42 and phosphorylated tau, thereby linking remote speech analysis with established biological measures []. High adherence and usability scores in remote assessments further support the scalability and acceptability of these tools in preclinical detection settings [].
In addition, remote protocols, including phone-based and app-based speech evaluations, have shown high adherence and user satisfaction among participants, even in preclinical stages of AD []. In particular, tasks such as picture description and narrative storytelling were successfully administered remotely and demonstrated sensitivity to differences in amyloid status []. These findings support the integration of speech-based tools into scalable, accessible cognitive monitoring frameworks, especially for individuals reporting subjective cognitive complaints.

3.4. Speech vs. Traditional Neuropsychological Testing

Spontaneous speech analysis may offer distinct advantages over conventional neuropsychological assessments, particularly in the context of early or subtle cognitive deficits. Several studies have shown that linguistic and paralinguistic features extracted from natural speech can predict disease progression, outperform traditional test scores, and provide insight into multiple cognitive domains [,].
Although automated and speech-based tools may currently be limited in their ability to capture nuanced qualitative language features with the same reliability as manual assessments [], their advantages in ecological validity, accessibility, and cost-effectiveness are considerable. Furthermore, these tools allow for continuous and remote monitoring, which is difficult to achieve with conventional testing.
However, challenges remain, as adding linguistic features to standard narrative description tests did not significantly improve predictive accuracy for future cognitive decline, suggesting that standalone speech analysis may not always yield additional diagnostic benefit []. Yet, as machine learning methods advance and data quality improves, the predictive and diagnostic utility of speech biomarkers is likely to grow, reinforcing their role alongside traditional cognitive assessments.

4. Discussion

The present review findings indicate that speech features—particularly from spontaneous and narrative speech—can serve as sensitive indicators of early cognitive changes due to AD pathology. According to current results, linguistic alterations, particularly in spontaneous and narrative speech, such as reduced fluency, slower speech rate, increased pauses, and decreased articulatory precision have been linked to biomarkers like amyloid and tau, even among asymptomatic individuals like SMD [,,]. These subtle linguistic changes often emerge before overt clinical symptoms and are detectable through detailed acoustic and linguistic analysis. Automated speech analysis has emerged as a promising non-invasive tool for remote screening, early detection, and longitudinal monitoring of cognitive decline. In addition, with regard to our results, natural language processing (NLP) and machine learning algorithms enabled the identification of speech patterns that distinguish normal aging from MCI and various stages of cognitive decline with high levels of accuracy and specificity [,,]. These technologies offer scalable, cost-effective, and user-friendly solutions, especially valuable in under-resourced settings or for populations with limited access to traditional healthcare services. In contrast, conventional neuropsychological assessments appear less sensitive to these early linguistic changes, highlighting the added value of speech-derived biomarkers in clinical evaluations [,,]. The present study leverages the potential that the performance of spontaneous speech has for the identification and very early diagnosis of cognitive alterations in older adults. Moreover, beyond diagnosis through conventional neuropsychological tests of language, the design and implementation of tasks that elicit spontaneous speech in real contexts have proven beneficial.
The findings are largely consistent with previous studies, reinforcing the growing consensus that speech features—particularly those derived from spontaneous and narrative speech—serve as sensitive early markers of cognitive decline. Our results align with similar studies [,] showing that subtle alterations in fluency, articulation, and speech timing can be detected even in asymptomatic individuals, such as those with SMD. Notably, automated speech analysis methods in our included studies, involved NLP and machine learning approaches, demonstrated high classification accuracy and predictive validity, similar to the AUC values (0.69–0.92) and accuracy rates (0.70–0.92) reported by similar studies such as Beltrami et al. (2018) [] and Eyigoz et al. (2020) []. These findings further support the idea that speech-derived biomarkers outperform conventional language assessments like the Boston Naming Test [], especially in identifying early, subtle cognitive changes that precede clinical impairment.
However, our review expands on the previous literature by emphasizing not only the diagnostic value of spontaneous speech but also the importance of ecologically valid, real-context elicitation tasks for capturing linguistic performance in its natural form. While similar studies [,] have acknowledged the role of discourse coherence, lexical retrieval, and sentence comprehension as early indicators, our included studies’ findings highlight the added value of context-sensitive speech tasks that may better reflect day-to-day communicative challenges in older adults. Furthermore, consistent with prior work [], we observed that digital tools not only enhance diagnostic sensitivity but also offer scalable, low-cost, and user-friendly solutions—a particularly important advantage for under-resourced settings.
Despite promising findings, several limitations must be addressed in the current review. A key limitation across the included studies lies in their considerable methodological heterogeneity, which complicates direct comparisons and the generalizability of findings. Variations in speech tasks (e.g., story recall, picture description, verbal fluency), speech processing tools (e.g., ELAN, Praat, WhisperX, OpenSMILE), and linguistic/acoustic features selected for analysis result in inconsistent outcome measures and interpretations [,,]. Sample characteristics also differ notably across studies with varying diagnostic criteria and biomarker assessment methods [,] (PET vs. CSF) for amyloid. Automated systems likewise face challenges: although ASR achieves high agreement with manual transcription for basic metrics like word count, more nuanced features (semantic cluster size, word frequency, fluency patterns) only show fair concordance [], potentially undermining clinical reliability. Furthermore, while some studies apply rigorous manual transcription and correction [], others rely on automated methods that may introduce transcription errors affecting downstream analyses. Many findings rely on small sample sizes or subgroup analyses [,], limiting statistical power, and effect sizes are often modest or lose significance after correction for multiple comparisons []. Finally, although digital voice markers show promise, their added value over established neuropsychological assessments remains uncertain in several studies [,], underscoring the need for longitudinal validation, harmonized protocols, and real-world clinical integration. Collectively, these limitations underscore the need for larger, multilingual cohorts, ecologically valid speech tasks, advanced transcription tools, and models aligned with neuropsychological theory.

5. Conclusions and Future Directions

Spontaneous speech analysis, through acoustic and temporal parameters such as silence duration, phrasal segment length, speech segment frequency, and long pauses, offers a rich window into the subtle cognitive and linguistic changes that may signal early memory decline in healthy older adults. These markers, reflecting the natural flow of unscripted verbal communication, are increasingly recognized for their potential in detecting subjective memory complaints and early stages of neurodegenerative disorders. Interdisciplinary research at the intersection of linguistics, neuroscience, and artificial intelligence (AI) has demonstrated that automated tools—especially those based on natural language processing and machine learning—can effectively capture nuanced speech patterns associated with early cognitive changes. These changes align with structural and functional brain alterations in memory- and language-related regions such as the hippocampus and prefrontal cortex. Future directions include integrating real-time speech analytics with neuroimaging and digital biomarkers to enhance early screening and monitoring, as well as implementing multilingual, cross-cultural studies to account for language variability. Such efforts could provide diverse datasets to train generative AI classification pipelines, leading to the development of new speech-based tasks and metrics tailored to detect early cognitive decline across populations. These directions hold promise for transforming spontaneous speech into a scalable, low-cost, and non-invasive diagnostic tool in proactive cognitive health.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/healthcare13222888/s1, PRISMA Flow Diagram.

Author Contributions

Conceptualization, S.S. and M.G.; methodology, M.G. and S.S.; validation, S.S., M.G. and S.K.; formal analysis, M.G.; investigation, M.G., S.S. and A.M.; data curation, S.K.; writing—original draft preparation, S.S. and M.G.; writing—review and editing, S.S., M.G., S.V. and A.M.; supervision, S.S., K.V. and G.M.; project administration, A.A., E.C., K.V. and G.M.; funding acquisition, G.M. and K.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the HORIZON project, COMFORTAGE, “Prediction, Monitoring and Personalized Recommendations for Prevention and Relief of Dementia and Frailty”, grant number ID: 101137301.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

Authors Athos Antoniades and Emily Charalambous were employed by the company Stremble Ventures Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abbreviations

The following abbreviations are used in this manuscript:
MCIMild Cognitive Impairment
SMDSubjective Memory Decline
ADAlzheimer Disease
SCDSubjective Cognitive Decline
SMISubjective Memory Impairment
SCCSubjective Cognitive Complaint
CDRGlobal Deterioration Scale
NLPNatural Language Processing
NDNarrative Discourse
ASRAutomatic Speech Recognition
VLTVerbal Learning Test
SVFSemantic Verbal Fluency
GeMAPSAcoustic Parameter Set
CSFCerebrospinal fluid
PLLRPhoneme Log-Likelihood Ratio

References

  1. Prince, M.J.; Comas-Herrera, A.; Knapp, M.; Guerchet, M.M.; Karagiannidou, M. World Alzheimer Report 2016—Improving Healthcare for People Living with Dementia: Coverage, Quality and Costs Now and in the Future; Alzheimer’s Disease International: London, UK, 2016. [Google Scholar]
  2. Petersen, R.C.; Morris, J.C. Mild cognitive impairment as a clinical entity and treatment target. Arch. Neurol. 2005, 62, 1160–1163; discussion 1167. [Google Scholar] [CrossRef]
  3. Ma, L. Depression, Anxiety, and Apathy in Mild Cognitive Impairment: Current Perspectives. Front. Aging Neurosci. 2020, 12, 9. [Google Scholar] [CrossRef]
  4. Breton, A.; Casey, D.; Arnaoutoglou, N.A. Cognitive tests for the detection of mild cognitive impairment (MCI), the prodromal stage of dementia: Meta-analysis of diagnostic accuracy studies. Int. J. Geriatr. Psychiatry 2019, 34, 233–242. [Google Scholar] [CrossRef]
  5. Choe, Y.M.; Byun, M.S.; Lee, J.H.; Sohn, B.K.; Lee, D.Y.; Kim, J.W. Subjective memory complaint as a useful tool for the early detection of Alzheimer’s disease. Neuropsychiatr. Dis. Treat. 2018, 14, 2451–2460. [Google Scholar] [CrossRef]
  6. Jessen, F.; Amariglio, R.E.; van Boxtel, M.; Breteler, M.; Ceccaldi, M.; Chételat, G.; Dubois, B.; Dufouil, C.; Ellis, K.A.; van der Flier, W.M.; et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimer’s Dement. 2014, 10, 844–852. [Google Scholar] [CrossRef]
  7. Liew, T.M. Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia. Alzheimer’s Res. Ther. 2020, 12, 107. [Google Scholar] [CrossRef] [PubMed]
  8. Parfenov, V.A.; Zakharov, V.V.; Kabaeva, A.R.; Vakhnina, N.V. Subjective cognitive decline as a predictor of future cognitive decline: A systematic review. Dement. Neuropsychol. 2020, 14, 248–257. [Google Scholar] [CrossRef] [PubMed]
  9. Warren, S.L.; Reid, E.; Whitfield, P.; Moustafa, A.A. Subjective memory complaints as a predictor of mild cognitive impairment and Alzheimer’s disease. Discov. Psychol. 2022, 2, 13. [Google Scholar] [CrossRef]
  10. Hsieh, S.-W.; Hsiao, S.-F.; Liaw, L.-J.; Huang, L.-C.; Yang, Y.-H. Effects of multiple training modalities in the elderly with subjective memory complaints: A pilot study. Medicine 2019, 98, e16506. [Google Scholar] [CrossRef] [PubMed]
  11. Carrasco, P.M.; Montenegro-Peña, M.; López-Higes, R.; Estrada, E.; Crespo, D.P.; Rubio, C.M.; Azorín, D.G. Subjective Memory Complaints in healthy older adults: Fewer complaints associated with depression and perceived health, more complaints also associated with lower memory performance. Arch. Gerontol. Geriatr. 2017, 70, 28–37. [Google Scholar] [CrossRef]
  12. Reisberg, B.; Ferris, S.H.; De Leon, M.J.; Crook, T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry 1982, 139, 1136–1139. [Google Scholar] [CrossRef] [PubMed]
  13. Yeung, A.; Iaboni, A.; Rochon, E.; Lavoie, M.; Santiago, C.; Yancheva, M.; Novikova, J.; Xu, M.; Robin, J.; Kaufman, L.D.; et al. Correlating natural language processing and automated speech analysis with clinician assessment to quantify speech-language changes in mild cognitive impairment and Alzheimer’s dementia. Alzheimer’s Res. Ther. 2021, 13, 109. [Google Scholar] [CrossRef] [PubMed]
  14. Constantino, C.D.; Eichorn, N.; Buder, E.H.; Beck, J.G.; Manning, W.H. The Speaker’s Experience of Stuttering: Measuring Spontaneity. J. Speech Lang. Hear Res. 2020, 63, 983–1001. [Google Scholar] [CrossRef]
  15. Ter Huurne, D.; Ramakers, I.; Possemis, N.; Banning, L.; Gruters, A.; Van Asbroeck, S.; König, A.; Linz, N.; Tröger, J.; Langel, K.; et al. The Accuracy of Speech and Linguistic Analysis in Early Diagnostics of Neurocognitive Disorders in a Memory Clinic Setting. Arch. Clin. Neuropsychol. 2023, 38, 667–676. [Google Scholar] [CrossRef]
  16. Kaser, A.N.; Lacritz, L.H.; Winiarski, H.R.; Gabirondo, P.; Schaffert, J.; Coca, A.J.; Jiménez-Raboso, J.; Rojo, T.; Zaldua, C.; Honorato, I.; et al. A novel speech analysis algorithm to detect cognitive impairment in a Spanish population. Front. Neurol. 2024, 15, 1342907. [Google Scholar] [CrossRef]
  17. García-Gutiérrez, F.; Alegret, M.; Marquié, M.; Muñoz, N.; Ortega, G.; Cano, A.; De Rojas, I.; García-González, P.; Olivé, C.; Puerta, R.; et al. Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer’s disease spectrum. Alzheimer’s Res. Ther. 2024, 16, 26. [Google Scholar] [CrossRef]
  18. Warner, N. Processes in Connected Speech. In The Cambridge Handbook of Phonetics; Knight, R.-A., Setter, J., Eds.; Cambridge University Press: Cambridge, UK, 2021; pp. 133–156. [Google Scholar]
  19. Mueller, K.D.; Hermann, B.; Mecollari, J.; Turkstra, L.S. Connected speech and language in mild cognitive impairment and Alzheimer’s disease: A review of picture description tasks. J. Clin. Exp. Neuropsychol. 2018, 40, 917–939. [Google Scholar] [CrossRef]
  20. Berisha, V.; Wang, S.; LaCross, A.; Liss, J. Tracking discourse complexity preceding Alzheimer’s disease diagnosis: A case study comparing the press conferences of Presidents Ronald Reagan and George Herbert Walker Bush. J. Alzheimer’s Dis. 2015, 45, 959–963. [Google Scholar] [CrossRef] [PubMed]
  21. Ahmed, S.; Haigh, A.-M.F.; de Jager, C.A.; Garrard, P. Connected speech as a marker of disease progression in autopsy-proven Alzheimer’s disease. Brain 2013, 136 Pt 12, 3727–3737. [Google Scholar] [CrossRef]
  22. Forbes-McKay, K.; Shanks, M.F.; Venneri, A. Profiling spontaneous speech decline in Alzheimer’s disease: A longitudinal study. Acta Neuropsychiatr. 2013, 25, 320–327. [Google Scholar] [CrossRef]
  23. Catricalà, E.; Della Rosa, P.A.; Plebani, V.; Perani, D.; Garrard, P.; Cappa, S.F. Semantic feature degradation and naming performance. Evidence from neurodegenerative disorders. Brain Lang. 2015, 147, 58–65. [Google Scholar] [CrossRef]
  24. de Lira, J.O.; Ortiz, K.Z.; Campanha, A.C.; Bertolucci, P.H.F.; Minett, T.S.C. Microlinguistic aspects of the oral narrative in patients with Alzheimer’s disease. Int. Psychogeriatr. 2011, 23, 404–412. [Google Scholar] [CrossRef]
  25. Fraser, K.C.; Meltzer, J.A.; Rudzicz, F. Linguistic Features Identify Alzheimer’s Disease in Narrative Speech. J. Alzheimer’s Dis. 2016, 49, 407–422. [Google Scholar] [CrossRef]
  26. Jarrold, W.; Peintner, B.; Wilkins, D.; Vergryi, D.; Richey, C.; Gorno-Tempini, M.L.; Ogar, J. Aided diagnosis of dementia type through computer-based analysis of spontaneous speech. In Proceedings of the Workshop on Computational Linguistics and Clinical Psychology: From Linguistic Signal to Clinical Reality, Baltimore, MA, USA, 27 June 2014; Resnik, P., Resnik, R., Mitchell, M., Eds.; Association for Computational Linguistics: Baltimore, MA, USA, 2014; pp. 27–37. [Google Scholar]
  27. Hoffmann, I.; Nemeth, D.; Dye, C.D.; Pákáski, M.; Irinyi, T.; Kálmán, J. Temporal parameters of spontaneous speech in Alzheimer’s disease. Int. J. Speech-Lang. Pathol. 2010, 12, 29–34. [Google Scholar] [CrossRef]
  28. Altmann, L.J.P.; Kempler, D.; Andersen, E.S. Speech errors in Alzheimer’s disease: Reevaluating morphosyntactic preservation. J. Speech Lang. Hear Res. 2001, 44, 1069–1082. [Google Scholar] [CrossRef]
  29. Cuetos, F.; Arango-Lasprilla, J.C.; Uribe, C.; Valencia, C.; Lopera, F. Linguistic changes in verbal expression: A preclinical marker of Alzheimer’s disease. J. Int. Neuropsychol. Soc. 2007, 13, 433–439. [Google Scholar] [CrossRef]
  30. Ferris, S.; Farlow, M. Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors. Clin. Interv. Aging 2013, 8, 1007–1014. [Google Scholar] [CrossRef]
  31. Yancheva, M.; Fraser, K.; Rudzicz, F. Using linguistic features longitudinally to predict clinical scores for Alzheimer’s disease and related dementias. In Proceedings of SLPAT 2015: 6th Workshop on Speech and Language Processing for Assistive Technologies, Dresden, Germany, 11 September 2015; Alexandersson, J., Altinsoy, E., Christensen, H., Ljunglöf, P., Portet, F., Rudzicz, F., Eds.; Association for Computational Linguistics: Baltimore, MA, USA, 2015; pp. 134–139. [Google Scholar]
  32. Ripich, D.N.; Carpenter, B.D.; Ziol, E.W. Conversational cohesion patterns in men and women with Alzheimer’s disease: A longitudinal study. Int. J. Lang. Commun. Disord. 2000, 35, 49–64. [Google Scholar] [CrossRef] [PubMed]
  33. Carlomagno, S.; Santoro, A.; Menditti, A.; Pandolfi, M.; Marini, A. Referential communication in Alzheimer’s type dementia. Cortex 2005, 41, 520–534. [Google Scholar] [CrossRef] [PubMed]
  34. Chapman, S.B.; Zientz, J.; Weiner, M.; Rosenberg, R.; Frawley, W.; Burns, M.H. Discourse changes in early Alzheimer disease, mild cognitive impairment, and normal aging. Alzheimer Dis. Assoc. Disord. 2002, 16, 177–186. [Google Scholar] [CrossRef] [PubMed]
  35. Drummond, C.; Coutinho, G.; Fonseca, R.P.; Assunã§Ã£O, N.; Teldeschi, A.; de Oliveira-Souza, R.; Moll, J.; Tovar-Moll, F.; Mattos, P. Deficits in narrative discourse elicited by visual stimuli are already present in patients with mild cognitive impairment. Front. Aging Neurosci. 2015, 7, 96. [Google Scholar] [CrossRef] [PubMed]
  36. Taler, V.; Phillips, N.A. Language performance in Alzheimer’s disease and mild cognitive impairment: A comparative review. J. Clin. Exp. Neuropsychol. 2008, 30, 501–556. [Google Scholar] [CrossRef] [PubMed]
  37. Snowdon, D.A. Healthy Aging and Dementia: Findings from the Nun Study. Ann. Intern. Med. 2003, 139, 450–454. [Google Scholar] [CrossRef] [PubMed]
  38. Garrard, P.; Maloney, L.M.; Hodges, J.R.; Patterson, K. The effects of very early Alzheimer’s disease on the characteristics of writing by a renowned author. Brain 2005, 128, 250–260. [Google Scholar] [CrossRef]
  39. Maruta, C.; Martins, I.P. May Subjective Language Complaints Predict Future Language Decline in Community-Dwelling Subjects? Front. Psychol. 2019, 10, 1974. [Google Scholar] [CrossRef]
  40. Verfaillie, S.C.; Witteman, J.; Slot, R.E.; Pruis, I.J.; Vermaat, L.E.; Prins, N.D.; Schiller, N.O.; van de Wiel, M.; Scheltens, P.; van Berckel, B.N.; et al. High amyloid burden is associated with fewer specific words during spontaneous speech in individuals with subjective cognitive decline. Neuropsychologia 2019, 131, 184–192. [Google Scholar] [CrossRef]
  41. Reeves, S.M.; Williams, V.; Blacker, D.; Woods, R.L. Further evaluation of narrative description as a measure of cognitive function in Alzheimer’s disease. Neuropsychology 2023, 37, 801–812. [Google Scholar] [CrossRef]
  42. Szatloczki, G.; Hoffmann, I.; Vincze, V.; Kalman, J.; Pakaski, M. Speaking in Alzheimer’s Disease, is That an Early Sign? Importance of Changes in Language Abilities in Alzheimer’s Disease. Front. Aging Neurosci. 2015, 7, 195. [Google Scholar] [CrossRef]
  43. Filiou, R.-P.; Bier, N.; Slegers, A.; Houzé, B.; Belchior, P.; Brambati, S.M. Connected speech assessment in the early detection of Alzheimer’s disease and mild cognitive impairment: A scoping review. Aphasiology 2020, 34, 723–755. [Google Scholar] [CrossRef]
  44. Toledo, C.M.; Aluísio, S.M.; dos Santos, L.B.; Brucki, S.M.D.; Trés, E.S.; de Oliveira, M.O.; Mansur, L.L. Analysis of macrolinguistic aspects of narratives from individuals with Alzheimer’s disease, mild cognitive impairment, and no cognitive impairment. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 2018, 10, 31–40. [Google Scholar] [CrossRef]
  45. Meilan, J.J.; Martinez-Sanchez, F.; Carro, J.; Carcavilla, N.; Ivanova, O. Voice Markers of Lexical Access in Mild Cognitive Impairment and Alzheimer’s Disease. Curr. Alzheimer Res. 2018, 15, 111–119. [Google Scholar] [CrossRef]
  46. Roark, B.; Mitchell, M.; Hosom, J.-P.; Hollingshead, K.; Kaye, J. Spoken Language Derived Measures for Detecting Mild Cognitive Impairment. IEEE Trans. Audio Speech Lang. Process. 2011, 19, 2081–2090. [Google Scholar] [CrossRef]
  47. Roark, B.; Mitchell, M.; Hollingshead, K. Syntactic complexity measures for detecting Mild Cognitive Impairment. In Biological, Translational, and Clinical Language Processing; Cohen, K.B., Demner-Fushman, D., Friedman, C., Hirschman, L., Pestian, J., Eds.; Association for Computational Linguistics: Baltimore, MA, USA, 2007; pp. 1–8. [Google Scholar]
  48. Chinaei, H.; Currie, L.C.; Danks, A.; Lin, H.; Mehta, T.; Rudzicz, F. Identifying and Avoiding Confusion in Dialogue with People with Alzheimer’s Disease. Comput. Linguist. 2017, 43, 377–406. [Google Scholar] [CrossRef]
  49. Yancheva, M.; Rudzicz, F. Vector-space topic models for detecting Alzheimer’s disease. In Proceedings of the 54th Annual Meeting of the Association for Computational Linguistics (Volume 1: Long Papers), Berlin, Germany, 7–12 August 2016; Erk, K., Smith, N.A., Eds.; Association for Computational Linguistics: Baltimore, MA, USA, 2016; pp. 2337–2346. [Google Scholar]
  50. López-De-Ipiña, K.; Solé-Casals, J.; Eguiraun, H.; Alonso, J.; Travieso, C.; Ezeiza, A.; Barroso, N.; Ecay-Torres, M.; Martinez-Lage, P.; Beitia, B. Feature selection for spontaneous speech analysis to aid in Alzheimer’s disease diagnosis: A fractal dimension approach. Comput. Speech Lang. 2015, 30, 43–60. [Google Scholar] [CrossRef]
  51. Kemper, S.; Greiner, L.H.; Marquis, J.G.; Prenovost, K.; Mitzner, T.L. Language decline across the life span: Findings from the Nun Study. Psychol. Aging. 2001, 16, 227–239. [Google Scholar] [CrossRef] [PubMed]
  52. Kintsch, W.; Keenan, J. Reading rate and retention as a function of the number of propositions in the base structure of sentences. Cogn. Psychol. 1973, 5, 257–274. [Google Scholar] [CrossRef]
  53. Almor, A.; Kempler, D.; MacDonald, M.C.; Andersen, E.S.; Tyler, L.K. Why do Alzheimer patients have difficulty with pronouns? Working memory, semantics, and reference in comprehension and production in Alzheimer’s disease. Brain Lang. 1999, 67, 202–227. [Google Scholar] [CrossRef]
  54. Kim, M.; Thompson, C.K. Verb deficits in Alzheimer’s disease and agrammatism: Implications for lexical organization. Brain Lang. 2004, 88, 1–20. [Google Scholar] [CrossRef] [PubMed]
  55. de la Fuente Garcia, S.; Ritchie, C.W.; Luz, S. Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer’s Disease: A Systematic Review. J. Alzheimer’s Dis. 2020, 78, 1547–1574. [Google Scholar] [CrossRef]
  56. Aramaki, E.; Shikata, S.; Miyabe, M.; Kinoshita, A. Vocabulary size in speech may be an early indicator of cognitive impairment. PLoS ONE 2016, 11, e0155195. [Google Scholar] [CrossRef] [PubMed]
  57. Graham, N.L.; Patterson, K.; Hodges, J.R. When More Yields Less: Speaking and Writing Deficits in Nonfluent Progressive Aphasia. Neurocase 2004, 10, 141–155. [Google Scholar] [CrossRef]
  58. Sajjadi, S.A.; Patterson, K.; Tomek, M.; Nestor, P.J. Abnormalities of connected speech in semantic dementia vs. Alzheimer’s disease. Aphasiology 2012, 26, 847–866. [Google Scholar] [CrossRef]
  59. Tomoeda, C.K.; Bayles, K.A.; Trosset, M.W.; Azuma, T.; McGeagh, A. Cross-sectional analysis of Alzheimer disease effects on oral discourse in a picture description task. Alzheimer Dis. Assoc. Disord. 1996, 10, 204–215. [Google Scholar] [CrossRef]
  60. Goodglass, H.; Kaplan, E. Boston Diagnostic Aphasia Examination Booklet; Lea & Febiger: Philadelphia, PA, USA, 1983. [Google Scholar]
  61. Giles, E.; Patterson, K.; Hodges, J.R. Performance on the Boston Cookie Theft picture description task in patients with early dementia of the Alzheimer’s type: Missing information. Aphasiology 1996, 10, 395–408. [Google Scholar] [CrossRef]
  62. Calzà, L.; Gagliardi, G.; Favretti, R.R.; Tamburini, F. Linguistic features and automatic classifiers for identifying mild cognitive impairment and dementia. Comput. Speech Lang. 2021, 65, 101113. [Google Scholar] [CrossRef]
  63. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLOS Med. 2009, 6, e1000097. [Google Scholar] [CrossRef]
  64. Young, C.B.; Smith, V.; Karjadi, C.; Grogan, S.; Ang, T.F.A.; Insel, P.S.; Henderson, V.W.; Sumner, M.; Poston, K.L.; Au, R.; et al. Speech patterns during memory recall relates to early tau burden across adulthood. Alzheimer’s Dement. 2024, 20, 2552–2563. [Google Scholar] [CrossRef]
  65. Xu, L.; Chen, K.; Mueller, K.D.; Liss, J.; Berisha, V. Articulatory precision from connected speech as a marker of cognitive decline in Alzheimer’s disease risk-enriched cohorts. J. Alzheimer’s Dis. 2025, 103, 476–486. [Google Scholar] [CrossRef] [PubMed]
  66. van den Berg, R.L.; Butterbrod, E.; de Boer, C.; Schlüter, L.; van Harten, A.C.; Teunissen, C.E.; van de Giessen, E.; van der Flier, W.M.; Sikkes, S.A.M. Amyloid-related changes in fluency in patients with subjective cognitive decline. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 2025, 17, e70063. [Google Scholar] [CrossRef]
  67. van den Berg, R.L.; de Boer, C.; Zwan, M.D.; Jutten, R.J.; van Liere, M.; van de Glind, M.-C.A.; Dubbelman, M.A.; Schlüter, L.M.; van Harten, A.C.; Teunissen, C.E.; et al. Digital remote assessment of speech acoustics in cognitively unimpaired adults: Feasibility, reliability and associations with amyloid pathology. Alzheimer’s Res. Ther. 2024, 16, 176. [Google Scholar] [CrossRef] [PubMed]
  68. Soroski, T.; Vasco, T.d.C.; Newton-Mason, S.; Granby, S.; Lewis, C.; Harisinghani, A.; Rizzo, M.; Conati, C.; Murray, G.; Carenini, G.; et al. Evaluating Web-Based Automatic Transcription for Alzheimer Speech Data: Transcript Comparison and Machine Learning Analysis. JMIR Aging 2022, 5, e33460. [Google Scholar] [CrossRef]
  69. König, A.; Köhler, S.; Tröger, J.; Düzel, E.; Glanz, W.; Butryn, M.; Mallick, E.; Priller, J.; Altenstein, S.; Spottke, A.; et al. Automated remote speech-based testing of individuals with cognitive decline: Bayesian agreement of transcription accuracy. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 2024, 16, e70011. [Google Scholar] [CrossRef]
  70. Konig, A.; Satt, A.; Sorin, A.; Hoory, R.; Derreumaux, A.; David, R.; Robert, P.H.; David, A. Use of Speech Analyses within a Mobile Application for the Assessment of Cognitive Impairment in Elderly People. Curr. Alzheimer Res. 2018, 15, 120–129. [Google Scholar] [CrossRef]
  71. Ter Huurne, D.; Possemis, N.; Banning, L.; Gruters, A.; König, A.; Linz, N.; Tröger, J.; Langel, K.; Verhey, F.; de Vugt, M.; et al. Validation of an Automated Speech Analysis of Cognitive Tasks within a Semiautomated Phone Assessment. Digit. Biomark. 2023, 7, 115–123. [Google Scholar] [CrossRef]
  72. Hajjar, I.; Okafor, M.; Choi, J.D.; Moore, E.; Abrol, A.; Calhoun, V.D.; Goldstein, F.C. Development of digital voice biomarkers and associations with cognition, cerebrospinal biomarkers, and neural representation in early Alzheimer’s disease. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 2023, 15, e12393. [Google Scholar] [CrossRef]
  73. Beltrami, D.; Gagliardi, G.; Favretti, R.R.; Ghidoni, E.; Tamburini, F.; Calzà, L. Speech Analysis by Natural Language Processing Techniques: A Possible Tool for Very Early Detection of Cognitive Decline? Front. Aging Neurosci. 2018, 10, 369. [Google Scholar] [CrossRef] [PubMed]
  74. López-Higes, R.; Rubio-Valdehita, S.; Fernandes, S.M.; Rodrigues, P.F.S. Differentiation between Normal Cognition and Subjective Cognitive Decline in Older Adults Using Discrepancy Scores Derived from Neuropsychological Tests. Geriatrics 2024, 9, 83. [Google Scholar] [CrossRef] [PubMed]
  75. Eyigoz, E.; Mathur, S.; Santamaria, M.; Cecchi, G.; Naylor, M. Linguistic markers predict onset of Alzheimer’s disease. eClinicalMedicine 2020, 28, 100583. [Google Scholar] [CrossRef] [PubMed]
  76. López-Higes, R.; Prados, J.M.; Rubio, S.; Montejo, P.; Del Río, D. Executive functions and linguistic performance in SCD older adults and healthy controls. Aging Neuropsychol. Cogn. 2017, 24, 717–734. [Google Scholar] [CrossRef] [PubMed]
  77. Ostrand, R.; Gunstad, J. Using Automatic Assessment of Speech Production to Predict Current and Future Cognitive Function in Older Adults. J. Geriatr. Psychiatry Neurol. 2021, 34, 357–369. [Google Scholar] [CrossRef]
  78. Robin, J.; Xu, M.; Kaufman, L.D.; Simpson, W. Using Digital Speech Assessments to Detect Early Signs of Cognitive Impairment. Front. Digit. Health 2021, 3, 749758. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.